Overview
Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-007)
Status:
Completed
Completed
Trial end date:
1969-12-31
1969-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this phase 3 study is to determine the safety and efficacy of cyclosporine in the treatment of dry eye syndrome.Phase:
Phase 3Details
Lead Sponsor:
Sirion Therapeutics, Inc.Treatments:
Cyclosporine
Cyclosporins
Criteria
Inclusion Criteria:- Diagnosis of moderate to severe dry eye syndrome with or without Sjogren's syndrome or
other autoimmune disease
Exclusion Criteria:
- Intraocular or refractive surgery in the study eye within 3 months prior to study
start
- Unwilling to discontinue use of contact lenses during the run-in and duration of the
study
- Pregnancy or lactation